The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wynn, T. A.
Right arrow Articles by Sher, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wynn, T. A.
Right arrow Articles by Sher, A.

The Journal of Immunology, Vol 157, Issue 9 4068-4078, Copyright © 1996 by American Association of Immunologists


ARTICLES

IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite

TA Wynn, A Reynolds, S James, AW Cheever, P Caspar, S Hieny, D Jankovic, M Strand and A Sher
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. tw12b@nih.gov

The production of Th1-type cytokines is associated with strong cell- mediated immunity, while Th2-type cytokines typically dominate humoral immune responses. In mice vaccinated a single time with attenuated cercariae of Schistosoma mansoni, the protection induced is associated with Th1 cytokine-dependent, cell-mediated immunity. In contrast, mice vaccinated multiple times display a more Th2-type dominant cytokine response and develop Ab-dependent resistance. We have previously shown that IL-12 enhances cell-mediated immunity in singly vaccinated mice. In the present study, we asked what effects administering IL-12 as an adjuvant would have on the development of a protective humoral response in multiply immunized animals. We found that multiply immunized/IL-12- treated mice displayed a marked increase in resistance to challenge infection, with some animals demonstrating complete protection. The IL- 12-vaccinated mice developed strongly polarized Th1 responses but, importantly, also showed significant increases in parasite-specific Ab and, in particular, IgG2a, IgG2b, and IgG1 isotypes. Passive transfer demonstrated an enhanced ability of serum from these animals to protect naive recipients. In addition, animals vaccinated in the presence of IL- 12 also developed macrophages with increased nitric oxide-dependent killing activity against the parasites. Together, these data demonstrate that IL-12, initially described as an adjuvant for cell- mediated immunity, may be used to simultaneously to promote both humoral and cell-mediated protective responses against infection.


This article has been cited by other articles:


Home page
Infect. Immun.Home page
T. Leenstra, L. P. Acosta, H.-W. Wu, G. C. Langdon, J. S. Solomon, D. L. Manalo, L. Su, M. Jiz, B. Jarilla, A. O. Pablo, et al.
T-Helper-2 Cytokine Responses to Sj97 Predict Resistance to Reinfection with Schistosoma japonicum
Infect. Immun., January 1, 2006; 74(1): 370 - 381.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Patel, D. Xu, P. Kewin, B. Choo-Kang, C. McSharry, N. C. Thomson, and F. Y. Liew
TLR2 Agonist Ameliorates Established Allergic Airway Inflammation by Promoting Th1 Response and Not via Regulatory T Cells
J. Immunol., June 15, 2005; 174(12): 7558 - 7563.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
K. G. Hogg, S. Kumkate, and A. P. Mountford
IL-10 regulates early IL-12-mediated immune responses induced by the radiation-attenuated schistosome vaccine
Int. Immunol., December 1, 2003; 15(12): 1451 - 1459.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Z. Su, M.-F. Tam, D. Jankovic, and M. M. Stevenson
Vaccination with Novel Immunostimulatory Adjuvants against Blood-Stage Malaria in Mice
Infect. Immun., September 1, 2003; 71(9): 5178 - 5187.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. M. Lynch, D. E. Briles, and D. W. Metzger
Increased Protection against Pneumococcal Disease by Mucosal Administration of Conjugate Vaccine plus Interleukin-12
Infect. Immun., August 1, 2003; 71(8): 4780 - 4788.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. G. Hogg, S. Kumkate, S. Anderson, and A. P. Mountford
Interleukin-12 p40 Secretion by Cutaneous CD11c+ and F4/80+ Cells Is a Major Feature of the Innate Immune Response in Mice That Develop Th1-Mediated Protective Immunity to Schistosomamansoni
Infect. Immun., June 1, 2003; 71(6): 3563 - 3571.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Su and M. M. Stevenson
IL-12 Is Required for Antibody-Mediated Protective Immunity Against Blood-Stage Plasmodiumchabaudi AS Malaria Infection in Mice
J. Immunol., February 1, 2002; 168(3): 1348 - 1355.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
B. P. Arulanandam, J. M. Lynch, D. E. Briles, S. Hollingshead, and D. W. Metzger
Intranasal Vaccination with Pneumococcal Surface Protein A and Interleukin-12 Augments Antibody-Mediated Opsonization and Protective Immunity against Streptococcus pneumoniae Infection
Infect. Immun., November 1, 2001; 69(11): 6718 - 6724.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Chen, Y. Wei, G. C. Sharp, and H. Braley-Mullen
Induction of Experimental Autoimmune Thyroiditis in IL-12-/- Mice
J. Immunol., August 1, 2001; 167(3): 1720 - 1727.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H.-W. Chen, C.-H. Pan, H.-W. Huan, M.-Y. Liau, J.-R. Chiang, and M.-H. Tao
Suppression of Immune Response and Protective Immunity to a Japanese Encephalitis Virus DNA Vaccine by Coadministration of an IL-12-Expressing Plasmid
J. Immunol., June 15, 2001; 166(12): 7419 - 7426.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. T. Maecker, G. Hansen, D. M. Walter, R. H. DeKruyff, S. Levy, and D. T. Umetsu
Vaccination with Allergen-IL-18 Fusion DNA Protects Against, and Reverses Established, Airway Hyperreactivity in a Murine Asthma Model
J. Immunol., January 15, 2001; 166(2): 959 - 965.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. P. Mountford, K. G. Hogg, P. S. Coulson, and F. Brombacher
Signaling via Interleukin-4 Receptor {alpha} Chain Is Required for Successful Vaccination against Schistosomiasis in BALB/c Mice
Infect. Immun., January 1, 2001; 69(1): 228 - 236.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Hussell and P. J. M. Openshaw
IL-12-Activated NK Cells Reduce Lung Eosinophilia to the Attachment Protein of Respiratory Syncytial Virus But Do Not Enhance the Severity of Illness in CD8 T Cell-Immunodeficient Conditions
J. Immunol., December 15, 2000; 165(12): 7109 - 7115.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Sfondrini, M. Rodolfo, M. Singh, M. P. Colombo, M. I. Colnaghi, S. Ménard, and A. Balsari
Cooperative Effects of Mycobacterium tuberculosis Ag38 Gene Transduction and Interleukin 12 in Vaccination against Spontaneous Tumor Development in Proto-neu Transgenic Mice
Cancer Res., July 1, 2000; 60(14): 3777 - 3781.
[Abstract] [Full Text]


Home page
Infect. Immun.Home page
C. M. Collazo, C. Miller, G. Yap, S. Hieny, P. Caspar, R. H. Schwartz, and A. Sher
Host Resistance and Immune Deviation in Pigeon Cytochrome c T-Cell Receptor Transgenic Mice Infected with Toxoplasma gondii
Infect. Immun., May 1, 2000; 68(5): 2713 - 2719.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
K. Tani, W. J. Murphy, O. Chertov, R. Salcedo, C. Y. Koh, I. Utsunomiya, S. Funakoshi, O. Asai, S. H. Herrmann, J. M. Wang, et al.
Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens
Int. Immunol., May 1, 2000; 12(5): 691 - 700.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Timmerman and R. Levy
Linkage of Foreign Carrier Protein to a Self-Tumor Antigen Enhances the Immunogenicity of a Pulsed Dendritic Cell Vaccine
J. Immunol., May 1, 2000; 164(9): 4797 - 4803.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. P. Arulanandam, J. N. Mittler, W. T. Lee, M. O'Toole, and D. W. Metzger
Neonatal Administration of IL-12 Enhances the Protective Efficacy of Antiviral Vaccines
J. Immunol., April 1, 2000; 164(7): 3698 - 3704.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. G. Chiaramonte, M. Hesse, A. W. Cheever, and T. A. Wynn
CpG Oligonucleotides Can Prophylactically Immunize Against Th2-Mediated Schistosome Egg-Induced Pathology by an IL-12-Independent Mechanism
J. Immunol., January 15, 2000; 164(2): 973 - 985.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. F. Hoffmann, S. L. James, A. W. Cheever, and T. A. Wynn
Studies with Double Cytokine-Deficient Mice Reveal That Highly Polarized Th1- and Th2-Type Cytokine and Antibody Responses Contribute Equally to Vaccine-Induced Immunity to Schistosoma mansoni
J. Immunol., July 15, 1999; 163(2): 927 - 938.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Sur, J. S. Wild, B. K. Choudhury, N. Sur, R. Alam, and D. M. Klinman
Long Term Prevention of Allergic Lung Inflammation in a Mouse Model of Asthma by CpG Oligodeoxynucleotides
J. Immunol., May 15, 1999; 162(10): 6284 - 6293.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. D. Bungiro Jr., M. Goldberg, P. K. Suri, and P. M. Knopf
Interleukin-12 as an Adjuvant for an Antischistosome Vaccine Consisting of Adult Worm Antigens: Protection of Rats from Cercarial Challenge
Infect. Immun., May 1, 1999; 67(5): 2340 - 2348.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
B. H. Segal, T. M. Doherty, T. A. Wynn, A. W. Cheever, A. Sher, and S. M. Holland
The p47phox-/- Mouse Model of Chronic Granulomatous Disease Has Normal Granuloma Formation and Cytokine Responses to Mycobacterium avium and Schistosoma mansoni Eggs
Infect. Immun., April 1, 1999; 67(4): 1659 - 1665.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Jankovic, T. A. Wynn, M. C. Kullberg, S. Hieny, P. Caspar, S. James, A. W. Cheever, and A. Sher
Optimal Vaccination Against Schistosoma mansoni Requires the Induction of Both B Cell- and IFN-{gamma}-Dependent Effector Mechanisms
J. Immunol., January 1, 1999; 162(1): 345 - 351.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Buchanan, B. P. Arulanandam, and D. W. Metzger
IL-12 Enhances Antibody Responses to T-Independent Polysaccharide Vaccines in the Absence of T and NK Cells
J. Immunol., November 15, 1998; 161(10): 5525 - 5533.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Gurunathan, K. R. Irvine, C.-Y. Wu, J. I. Cohen, E. Thomas, C. Prussin, N. P. Restifo, and R. A. Seder
CD40 Ligand/Trimer DNA Enhances Both Humoral and Cellular Immune Responses and Induces Protective Immunity to Infectious and Tumor Challenge
J. Immunol., November 1, 1998; 161(9): 4563 - 4571.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Dubois, C. Massacrier, B. Vanbervliet, J. Fayette, F. Briere, J. Banchereau, and C. Caux
Critical Role of IL-12 in Dendritic Cell-Induced Differentiation of Naive B Lymphocytes
J. Immunol., September 1, 1998; 161(5): 2223 - 2231.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. L. James, A. W. Cheever, P. Caspar, and T. A. Wynn
Inducible Nitric Oxide Synthase-Deficient Mice Develop Enhanced Type 1 Cytokine-Associated Cellular and Humoral Immune Responses after Vaccination with Attenuated Schistosoma mansoni Cercariae but Display Partially Reduced Resistance
Infect. Immun., August 1, 1998; 66(8): 3510 - 3518.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. N. Kline, T. J. Waldschmidt, T. R. Businga, J. E. Lemish, J. V. Weinstock, P. S. Thorne, and A. M. Krieg
Cutting Edge: Modulation of Airway Inflammation by CpG Oligodeoxynucleotides in a Murine Model of Asthma
J. Immunol., March 15, 1998; 160(6): 2555 - 2559.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Peng, J. E. Remacle, A. Kasran, D. Huylebroeck, and J. L. Ceuppens
IL-12 Up-Regulates CD40 Ligand (CD154) Expression on Human T Cells
J. Immunol., February 1, 1998; 160(3): 1166 - 1172.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.